Enoxaparin Sodium Injection
Product Images NDC 0955-1012

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 0955-1012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (20635579 C92d 4f6c A332 1096d51002f2 01)

An illustration showing two hands preparing an injection syringe. One hand holds a small cap or protective cover, and the other hand holds a syringe, with arrows indicating the motion of removing the cap from the syringe.*

FDA Label Image

Figure B (20635579 C92d 4f6c A332 1096d51002f2 02)

Illustration showing a hand administering a subcutaneous injection into the skin of the forearm using a syringe. The image depicts the injection technique commonly used for enoxaparin sodium subcutaneous injection.*

FDA Label Image

Figure C (20635579 C92d 4f6c A332 1096d51002f2 03)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin of a patient's upper arm or thigh. A blue arrow indicates the direction of the injection, consistent with the subcutaneous route for Enoxaparin sodium injection.*

FDA Label Image

Figure D (20635579 C92d 4f6c A332 1096d51002f2 04)

Illustration showing a hand holding an Enoxaparin sodium prefilled syringe injection with an arrow indicating the motion of pressing or activating the syringe plunger. The image demonstrates proper handling or administration technique for subcutaneous injection.*

FDA Label Image

Figure E (20635579 C92d 4f6c A332 1096d51002f2 05)

An instructional illustration shows a gloved hand disposing of a syringe into a container marked with a red biohazard symbol. A blue arrow indicates the downward motion for proper syringe disposal.*

FDA Label Image

Chemical Structure (20635579 C92d 4f6c A332 1096d51002f2 06)

Chemical structure diagram of enoxaparin sodium, showing repetitive disaccharide units with specified groups R1 (H or SO3Na) and R2 (SO3Na or COCH3) attached to the molecular backbone.*

FDA Label Image

Chemical Structure (20635579 C92d 4f6c A332 1096d51002f2 07)

Chemical structure diagram of enoxaparin sodium, depicting its molecular framework including sodium carboxylate and sulfonate groups. The image illustrates the key components of the compound's polysaccharide backbone used as an anticoagulant agent.*

FDA Label Image

Figure 1 (20635579 C92d 4f6c A332 1096d51002f2 08)

A forest plot chart showing relative risk comparisons between enoxaparin sodium and unfractionated heparin (UFH) across various patient subgroups, including sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent used, time to treatment, and PCI status. The chart presents the number of patients per subgroup, risk percentages for UFH and enoxaparin, and the percentage reduction in risk with enoxaparin treatment.*

FDA Label Image

Figure 2 (20635579 C92d 4f6c A332 1096d51002f2 09)

A line graph depicting the hazard distribution function over time to death or myocardial re-infarction (days) comparing Enoxaparin and UFH treatments. Data points show a higher hazard for UFH than Enoxaparin. An inset graph shows similar hazard comparison at 1 year with corresponding p-values from log-rank tests. A table below lists number at risk for both treatments at various time points.*

FDA Label Image

Figure (20635579 C92d 4f6c A332 1096d51002f2 10)

Illustration showing a syringe before and after use, labeled with parts including the plunger rod, needle, needle cap, and protective sleeve. The syringe is depicted with the needle and plunger rod extended before use and the plunger rod retracted with the protective sleeve in place after use.*

FDA Label Image

Figure A (20635579 C92d 4f6c A332 1096d51002f2 11)

Illustration showing components for subcutaneous injection of enoxaparin sodium. It includes a prefilled syringe labeled Enoxaparin Sodium, a cotton ball or gauze, an alcohol wipe, a small adhesive bandage, and a sharps disposal container for safe syringe disposal.*

FDA Label Image

Figure B (20635579 C92d 4f6c A332 1096d51002f2 12)

An instructional illustration showing two hands preparing a prefilled syringe injection device. One hand is peeling off a protective label or film, while the other holds the syringe with a visible dose scale and plunger, demonstrating the steps to ready the enoxaparin sodium subcutaneous injection for use.*

FDA Label Image

Figure C (20635579 C92d 4f6c A332 1096d51002f2 13)

Enoxaparin sodium injection in prefilled syringe form, featuring a clear barrel with graduated markings and a plunger. The syringe is designed for subcutaneous administration and includes a black stopper and needle cover. An expiration date area is indicated near the plunger.*

FDA Label Image

Figure D (20635579 C92d 4f6c A332 1096d51002f2 14)

An instructional diagram of a prefilled syringe for enoxaparin sodium injection, subcutaneous route. The image shows the syringe barrel filled with clear liquid, the plunger, and needle cover, illustrating syringe component labeling without specific dosage details.*

FDA Label Image

Figure E (20635579 C92d 4f6c A332 1096d51002f2 15)

An instructional medical illustration showing the lower abdominal area with two shaded rectangular regions on either side, indicating recommended injection sites for subcutaneous administration.*

FDA Label Image

Figure F (20635579 C92d 4f6c A332 1096d51002f2 16)

Illustration showing a hand applying a small adhesive patch or device to the lower abdomen, suggesting preparation for a subcutaneous injection site, consistent with use instructions for Enoxaparin sodium injection.*

FDA Label Image

Figure G (20635579 C92d 4f6c A332 1096d51002f2 17)

An instructional illustration showing two hands preparing an injection syringe. One hand holds the syringe with a visible plunger and needle, while the other hand holds a protective needle cap with arrows indicating removal direction. The image depicts the step for removing the needle cap before administering a subcutaneous injection.*

FDA Label Image

Figure H (20635579 C92d 4f6c A332 1096d51002f2 18)

An instructional diagram showing how to hold and set the dose on a prefilled syringe injector. The hand is holding the injector with the thumb pressing on the plunger. An arrow points downward, indicating the direction to push the plunger. The text prompts to 'Set your dose.'*

FDA Label Image

Figure I (20635579 C92d 4f6c A332 1096d51002f2 19)

Instructional illustration showing a person's hand pinching the skin near the abdomen, likely to demonstrate preparing for a subcutaneous injection.*

FDA Label Image

Figure J (20635579 C92d 4f6c A332 1096d51002f2 20)

An instructional diagram showing the proper technique for subcutaneous injection. The illustration depicts a hand holding a syringe positioned at a 90-degree angle to the skin, indicating how to insert the needle for subcutaneous administration.*

FDA Label Image

Figure K (20635579 C92d 4f6c A332 1096d51002f2 21)

An instructional illustration showing a hand administering a subcutaneous injection into the abdominal area using a prefilled syringe. The other hand is slightly pinching the skin to prepare for the injection. An arrow indicates the direction of injection, demonstrating proper subcutaneous injection technique.*

FDA Label Image

Figure L (20635579 C92d 4f6c A332 1096d51002f2 22)

An instructional illustration showing proper technique for subcutaneous injection. The image depicts a hand holding a syringe and preparing to inject into the abdominal skin, with another hand pinching the skin to facilitate the injection.*

FDA Label Image

Figure M (20635579 C92d 4f6c A332 1096d51002f2 23)

An instructional illustration showing a hand holding an Enoxaparin sodium injection syringe with a protective sleeve. The image emphasizes a clicking motion to engage or secure the protective sleeve on the syringe, guiding proper usage technique.*

FDA Label Image

Figure N (20635579 C92d 4f6c A332 1096d51002f2 24)

An instructional illustration showing the proper disposal of a syringe with a needle cap into a labeled Sharps Disposal Container. A hand is holding the syringe above the container, demonstrating safe needle disposal practices.*

FDA Label Image

Principal Display Panel (30 mg/0.3 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 30 mg/0.3 mL single dose syringes with automatic safety device by Sanofi-Aventis U.S. LLC (Winthrop). The box contains 10 subcutaneous injection syringes. Label includes usage warnings, storage instructions, and directions for using the safety device on the syringe.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Syringe Carton)

The packaging label for Enoxaparin Sodium Injection 40 mg/0.4 mL by Sanofi-Aventis U.S. LLC features a predominantly white and orange color scheme with purple accents. It indicates the product is for subcutaneous use and contains ten 0.4 mL single-dose syringes with automatic safety devices. The label includes manufacturer and storage information and the Winthrop logo.*

FDA Label Image

Principal Display Panel (60 mg/0.6 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 60 mg/0.6 mL, a subcutaneous injection by Sanofi-Aventis U.S. LLC under the Winthrop brand. The label shows that the product contains ten 0.6 mL single-dose syringes with automatic safety devices. Storage instructions and barcode are also included on the label.*

FDA Label Image

Principal Display Panel (80 mg/0.8 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 80 mg/0.8 mL by Winthrop, a Sanofi company. The label indicates the product is for subcutaneous use and comes in ten 0.8 mL single-dose syringes with an automatic safety device. The label includes storage instructions, manufacturer details, and barcode.*

FDA Label Image

Principal Display Panel (100 mg/1 mL Syringe Carton)

Carton packaging for Enoxaparin Sodium Injection 100 mg/mL by Sanofi-Aventis U.S. LLC. The label includes dosage form as injection for subcutaneous use, with ten 1 mL single-dose syringes featuring an automatic safety device. The packaging displays the Winthrop brand, product storage instructions, and bar code.*

FDA Label Image

Principal Display Panel (120 mg/0.8 mL Syringe Carton)

Carton packaging label for Enoxaparin Sodium Injection 120 mg/0.8 mL by Sanofi-Aventis U.S. LLC. The label shows dosing in ten 0.8 mL single-dose syringes for subcutaneous use with an automatic safety device. Branding includes Winthrop and Sanofi logos with storage and administration instructions.*

FDA Label Image

Principal Display Panel (150 mg/1 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 150 mg/mL by Winthrop, a Sanofi company. The label indicates the product is for subcutaneous use and comes in ten 1 mL single-dose syringes with an automatic safety device. The label includes storage instructions, dosage information, and indicates it is an Rx only product.*

FDA Label Image

Principal Display Panel (300 mg /3 mL Vial Carton)

Carton label for Enoxaparin Sodium Injection 300 mg/3 mL (100 mg/mL) by Sanofi-Aventis U.S. LLC. The label includes branding for Winthrop, specifies subcutaneous or intravenous use, and indicates the vial is a 3 mL multiple-dose vial. The label provides storage instructions and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.